Post-Conference Survey

TOXINS 2022 NAR Conference: Basic Science and Clinical Aspects of Botulinum and Other Neurotoxins, New Orleans, Louisiana, United States, 12/01/2022-15/01/2022 has been granted 4 European CME credits (ECMEC^®s) by the European Accreditation Council for Continuing Medical Education (EACCME^®).

Please complete the evaluation/survey below. Within 2 weeks of completing your evaluation/survey, you will receive an email with a link to download your CME Certificate and Certificate of Attendance.

Name Badge ID*

Full Name*

Enter your first and last names as you would like them to appear on your certificates.

First Last

Email*

Enter the email you used to register for TOXINS 2021.

INA Username

If you are an INA Member, please enter your username below.

Country of Origin

Degree*

Are you a:*

Physician
Scientist
Other

Please specify your professional status*

What is your specialty focus?*

Please specify your specialty focus*

Number of years in practice/research:*

Type of Practice:*

Please specify type of practice*

Self-Assessment

How did this conference affect your ability to:

(A) Review the mechanisms of action and pharmacology of various botulinum neurotoxin serotypes and preparations, in order to understand their therapeutic effect

(B) Evaluate clinical data, evidence-based recommendations, and practical experience in the use of botulinum neurotoxins for multiple and diverse clinical conditions, in order to properly assess and select appropriate patients for neurotoxin therapy

(C) Demonstrate best practice procedures and techniques for neurotoxin injections, in order to improve clinical skills and optimize patient outcomes in a wide range of clinical disorders

(D) Identify the most up-to-date scientific and clinical research, in order to enhance understanding of the science and clinical utility of neurotoxins

(E) Promote interaction and cooperation among a wide range of scientific and clinical disciplines, in order to advance research and education relevant to the science and therapeutic application of botulinum and other neurotoxins

Which of the above learning objectives is most important to you?

Did you achieve the learning goals you identified at the beginning of the conference?

Yes
No

Was the presented information well balanced and consistently supported by a valid scientific evidence base?

The knowledge of skills gained from the conference can be applied to my work.

Yes
No

Clinicians (if applicable)

As a result of this conference, I will likely change my practice in the following areas: (Check all areas that apply)

Patient evaluation
Clinical assessment
Selection of optimal therapeutic option(s)
Dosing and administration of botulinum neurotoxins
Localization of neurotoxin injections
Documentation of patient outcomes
Other

If you answered "Other" please specify

I will make the following specific change in my practice.

Basic Scientists (if applicable)

This activity should improve my:

	Strongly Agree	Agree	Neutral	Disagree	Strongly Disagree
Ability to evaluate the latest clinical and scientific research into botulinum neurotoxins
Understanding of the clinical utility of botulinum neurotoxins
Understanding of potential new therapeutic applications of botulinum neurotoxins
Biomedical knowledge of botulinum and other neurotoxins and their application in enhancing therapeutics and improving care

As a result of this conference, I will likely change my research in the following areas: (check all areas that apply)

Please evaluate the speakers:

Overall Evaluation

	Excellent	Good	Fair	Poor
Targeting Botulinum Toxin to Distal Sites and Diverse Nerve Terminals (Matteo Caleo)
Receptor Interactions of Botulinum Toxin: The “Sweet” Spots of BoNT/A and BoNT/E (Rongsheng Jin)
Basis of Movement Control and Why Botulinum Toxin Should Influence It (Alfredo Berardelli)
Guidance, Localization, Optimal Placement of Botulinum Toxin: What Works Best? In Adult and Pediatric Spasticity (Katharine Alter)
Guidance, Localization, and Optimal Placement of Botulinum Toxin: Cervical Dystonia (Richard Barbano)
Guidance, Localization, Optimal Placement of Botulinum Toxin: What Works Best? In Limb Dystonia & Tremor (David Simpson)
Cosmetic Botulinum Toxin: Duration, Clinical Implications, and Uses (Nowell Solish)

Presentation free of commercial bias?

	No*	Yes
Targeting Botulinum Toxin to Distal Sites and Diverse Nerve Terminals (Matteo Caleo)
Receptor Interactions of Botulinum Toxin: The “Sweet” Spots of BoNT/A and BoNT/E (Rongsheng Jin)
Basis of Movement Control and Why Botulinum Toxin Should Influence It (Alfredo Berardelli)
Guidance, Localization, Optimal Placement of Botulinum Toxin: What Works Best? In Adult and Pediatric Spasticity (Katharine Alter)
Guidance, Localization, and Optimal Placement of Botulinum Toxin: Cervical Dystonia (Richard Barbano)
Guidance, Localization, Optimal Placement of Botulinum Toxin: What Works Best? In Limb Dystonia & Tremor (David Simpson)
Cosmetic Botulinum Toxin: Duration, Clinical Implications, and Uses (Nowell Solish)

Applicable to my research

	Yes	No
Targeting Botulinum Toxin to Distal Sites and Diverse Nerve Terminals (Matteo Caleo)
Receptor Interactions of Botulinum Toxin: The “Sweet” Spots of BoNT/A and BoNT/E (Rongsheng Jin)
Basis of Movement Control and Why Botulinum Toxin Should Influence It (Alfredo Berardelli)
Guidance, Localization, Optimal Placement of Botulinum Toxin: What Works Best? In Adult and Pediatric Spasticity (Katharine Alter)
Guidance, Localization, and Optimal Placement of Botulinum Toxin: Cervical Dystonia (Richard Barbano)
Guidance, Localization, Optimal Placement of Botulinum Toxin: What Works Best? In Limb Dystonia & Tremor (David Simpson)
Cosmetic Botulinum Toxin: Duration, Clinical Implications, and Uses (Nowell Solish)

*If you answered “No, this presentation was not free of commercial bias”, on any of the above, please explain your reason(s).

Suitability of formats used during the event

Was there adequate time available for discussions, questions & answers and learner engagement?

Can you indicate any innovative elements during the activity?

Please evaluate this activity as a whole:

Overall Evaluation

Overall, I would rate TOXINS 2021 as:

Excellent
Good
Fair
Poor

What was the most effective aspect(s) of this conference and why?

What was the least effective aspect(s) of this conference?

What topics, if any, still remain unclear to you?

Did all the faculty members provide their potential conflict of interest declaration with the sponsor(s) as a second slide of their presentation?

Suggestions for any specific lectures/topics that you would like covered at future TOXINS Conferences.

Additional comments

Self-Assessment

Clinicians (if applicable)

Basic Scientists (if applicable)

Please evaluate the speakers:

Suitability of formats used during the event

Member Login

TOXINS 2022

Join Our Mailing List

	Excellent	Good	Fair	Poor
Program content
Relevance to my clinical practice/research
Effectiveness in meeting identified need